{"organizations": [], "uuid": "3eb32778d2da18243b769c9d88fabb20f00a209b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 8, "shares": 8, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180206.html", "section_title": "Archive News &amp; Video for Tuesday, 06 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/usa-opioids-litigation/alabama-sues-oxycontin-maker-purdue-pharma-over-opioid-epidemic-idUSL2N1PW178", "country": "US", "domain_rank": 408, "title": "Alabama sues OxyContin maker Purdue Pharma over opioid epidemic", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-02-07T00:44:00.000+02:00", "replies_count": 0, "uuid": "3eb32778d2da18243b769c9d88fabb20f00a209b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/usa-opioids-litigation/alabama-sues-oxycontin-maker-purdue-pharma-over-opioid-epidemic-idUSL2N1PW178", "ord_in_thread": 0, "title": "Alabama sues OxyContin maker Purdue Pharma over opioid epidemic", "locations": [], "entities": {"persons": [{"name": "nate raymond", "sentiment": "none"}, {"name": "chizu nomiyama", "sentiment": "none"}, {"name": "steve marshall", "sentiment": "none"}], "locations": [{"name": "alabama", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}], "organizations": [{"name": "purdue pharma", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "purdue pharma lp", "sentiment": "none"}, {"name": "purdue", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 6 (Reuters) - Alabama on Tuesday became the latest state to file a lawsuit accusing OxyContin maker Purdue Pharma LP of fueling the opioid epidemic by deceptively marketing prescription painkillers to generate billions of dollars in sales.\nAlabama Attorney General Steve Marshall alleged in a lawsuit filed in a federal court that Purdue misrepresented the risks and benefits of opioids, enabling the widespread prescribing of the drugs for chronic pain conditions. (Reporting by Nate Raymond in Boston Editing by Chizu Nomiyama)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-07T00:44:00.000+02:00", "crawled": "2018-02-07T22:13:48.000+02:00", "highlightTitle": ""}